Literature DB >> 4110695

[Corynebacterium parvum in advanced cancers. 1st evaluation of the therapeutic activity of this immunostimulin].

L Israël, B Halpern.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4110695

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


× No keyword cloud information.
  9 in total

1.  Cancer and the immunity system--1977.

Authors:  R A Good
Journal:  West J Med       Date:  1977-02

Review 2.  Immunology of bronchial carcinoma.

Authors:  D A Evans
Journal:  Thorax       Date:  1976-10       Impact factor: 9.139

3.  Intrapleural Corynebacterium parvum for malignant pleural effusions.

Authors:  R Felletti; C Ravazzoni
Journal:  Thorax       Date:  1983-01       Impact factor: 9.139

4.  Personal experience with Corynebacterium parvum in human cancers.

Authors:  L Israël; R Edelstein
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

5.  Immunotherapy of cancer.

Authors:  E C Holmes; D L Morton; F R Eilber
Journal:  West J Med       Date:  1977-02

6.  Protection against herpes simplex virus infection in mice by Corynebacterium parvum.

Authors:  H Kirchner; H M Hirt; K Munk
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

7.  Nutritional requirements of anaerobic coryneforms.

Authors:  D A Ferguson; C S Cummins
Journal:  J Bacteriol       Date:  1978-09       Impact factor: 3.490

8.  The complications of intravenous Corynebacterium parvum infusion.

Authors:  P G Gill; P J Morris; M Kettlewell
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

9.  Intrapleural immunotherapy with Corynebacterium parvum in recurrent malignant pleural effusions.

Authors:  J W Millar; A M Hunter; N W Horne
Journal:  Thorax       Date:  1980-11       Impact factor: 9.139

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.